Softwr

Healthcare · head to head

Hinge Health vs Lunit

Hinge Health logo

Hinge Health

Healthcare

Digital musculoskeletal health platform

From
On request
Rated
-
Lunit logo

Lunit

Healthcare

FDA cleared and CE marked AI for mammography, tomosynthesis and chest radiography

From
On request
Rated
-

The short version

  • Each has a real cost: Hinge Health no specific pricing rates published; uses value-based pricing model negotiated with health plans and PBMs; Lunit the regulatory permission differs by product and by region, and INSIGHT Risk has been filed with the FDA but not cleared, so a buyer who reads a corporate press release rather than the specific clearance for their product and jurisdiction will plan a deployment they cannot legally run.
  • They diverge on capability: Hinge Health covers Physical Therapy, Lunit covers Lunit INSIGHT MMG.
  • Prices and features above were last checked on 1 September 2026.

Where they differ

Only the attributes on which Hinge Health and Lunit actually diverge.

Attributes where Hinge Health and Lunit differ
AttributeHinge HealthLunit
PlatformsWeb, MobileWeb
Founded2015Unknown

Identical on both: starting price (On request), pricing model (quote), free tier (No), user rating (Not yet rated), category (Healthcare).

What each one covers

Drawn from each product's published feature list. An absence here means we hold no record of it - not that the product lacks it.

Only in Hinge Health

  • Physical Therapy
  • Strength Training
  • Mental Health Support
  • Pain Management
  • Progress Tracking
  • Coach Support
  • Health Plans
  • Employers

Only in Lunit

  • Lunit INSIGHT MMG
  • Lunit INSIGHT DBT
  • Lunit INSIGHT CXR
  • Volpara density assessment
  • Volpara RiskPathways
  • Volpara dose tracking
  • PACS and mammography workstation integration

What people use each for

The jobs each tool is most often brought in to do.

Hinge Health

  • Patient Carenot Lunit
  • Medical Recordsnot Lunit
  • Practice Managementnot Lunit
  • Telehealthnot Lunit

Lunit

  • A national breast screening programme evaluating AI as a second reader to reduce double reading workload where two human readers are currently mandatednot Hinge Health
  • A breast centre that moved to tomosynthesis and now has reading times it cannot staff, wanting detection support on DBT specificallynot Hinge Health
  • An American breast imaging centre needing automated volumetric density assessment to meet patient density notification requirements, which is what Volpara is bought fornot Hinge Health
  • A tuberculosis or lung screening programme in a high volume, radiologist scarce setting using chest radiography triage to prioritise filmsnot Hinge Health

Where each one falls short

Documented limitations, not opinions. Every one is a constraint you would hit in normal use.

Hinge Health

  • No specific pricing rates published; uses value-based pricing model negotiated with health plans and PBMs

Lunit

  • The regulatory permission differs by product and by region, and INSIGHT Risk has been filed with the FDA but not cleared, so a buyer who reads a corporate press release rather than the specific clearance for their product and jurisdiction will plan a deployment they cannot legally run.
  • Detection AI changes recall rates in screening, and the downstream cost of additional diagnostic workup lands on the programme rather than on the software budget, which is the cost most screening business cases omit.
  • Performance is sensitive to the mammography vendor and acquisition protocol, so published results from a Hologic estate do not transfer to a GE or Siemens estate without local validation the buyer must fund.
  • MMG, DBT and CXR are licensed separately and Volpara modules are separate again, so a breast centre wanting detection, density and risk pathways is assembling four line items rather than buying one product.
  • Using AI as a replacement for one of two human readers is a workforce and liability decision that regulators and professional bodies treat differently in each country, so the saving that justifies the purchase may not be permitted where you operate.

Pricing, plan by plan

Hinge Health

On request

No published plan breakdown. See the Hinge Health review.

Lunit

On request
  • Lunit INSIGHT$undefined/year
    • Priced per study or per annual examination volume by product
    • MMG, DBT and CXR licensed separately
    • Volpara density and RiskPathways modules quoted separately

Which should you pick?

Choose Hinge Health if

  • You need physical therapy.
  • You work on Web, Mobile.
  • You also want strength training.

Choose Lunit if

  • You need lunit insight mmg.
  • You also want lunit insight dbt.

Questions people ask

Is Hinge Health or Lunit better?
Neither clearly leads. Hinge Health starts at On request and Lunit at On request, and user ratings are close enough to be indistinguishable. Choose on capability and platform support.
Which is cheaper, Hinge Health or Lunit?
Hinge Health starts at On request and Lunit at On request.
Does Hinge Health or Lunit run on more platforms?
Hinge Health runs on Web, Mobile. Lunit runs on Web.
What is Hinge Health best used for?
Hinge Health is most often used for patient care, medical records, practice management, telehealth. Of those, patient care and medical records are not what Lunit is typically brought in for.
What can Hinge Health do that Lunit cannot?
Hinge Health covers Physical Therapy, Strength Training, Mental Health Support, Pain Management. Lunit covers Lunit INSIGHT MMG, Lunit INSIGHT DBT, Lunit INSIGHT CXR, Volpara density assessment.

Answered from the vendors’ own pages

Hinge Health: How much does Hinge Health cost?

Hinge Health uses value-based pricing negotiated directly with payers. Individual pricing not disclosed on their website. For individual coverage, enrollment is through your health plan. Organizations should request a business demo.

Source
Lunit: Is Lunit FDA cleared?

Yes for specific products. INSIGHT MMG, INSIGHT DBT and INSIGHT CXR Triage hold FDA 510(k) clearances. INSIGHT Risk, the five year risk prediction model, has been filed but was not cleared at the time of writing.

Lunit: Can Lunit replace a second human reader in screening?

That depends entirely on your jurisdiction and professional body guidance, not on the software. The CE mark permits clinical use; it does not authorise a workforce model.

Lunit: What did the Volpara acquisition add?

Volumetric breast density measurement, dose tracking and RiskPathways high risk programme management, which are the things American breast centres buy for density notification compliance rather than for detection.

Lunit: Is pricing published?

No. It is quoted per study or per annual volume, by product, with on premises and cloud priced differently.

Share

Related pages

Other head to heads